RNA inhibition highlights Cyclin D1 as a potential therapeutic target for mantle cell lymphoma

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Weinstein, Shiri ^a   Emmanuel, Rafi ^a   Jacobi, Ashley M ^b   Abraham, Avigdor ^c   Behlke, Mark A ^b   Sprague, Andrew G ^d   Novobrantseva, Tatiana I ^d   Nagler, Arnon ^c   Peer, Dan ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b INTEGRATED DNA TECHNOLOGIES   (United States)

^c SHEBA MEDICAL CENTER   (Israel)

^d ALNYLAM PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; MESSENGER RNA; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; G1 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION REGULATION; GENE SILENCING; GROWTH RETARDATION; LYMPHOMA CELL LINE; MANTLE CELL LYMPHOMA; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; RNA INTERFERENCE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CYCLIN D1; DEAD-BOX RNA HELICASES; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; LYMPHOMA, MANTLE-CELL; RIBONUCLEASE III; RNA; RNA INTERFERENCE;

EID: 84865052732     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0043343     Document Type: Article

References (16)

1. Jares P, Colomer D, Campo E, (2007) Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics. Nat Rev Cancer 7: 750-762.
2. Hunter T, Pines J, (1994) Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell 79: 573-582.
3. Sherr CJ, (1996) Cancer cell cycles. Science 274: 1672-1677.
4. Sherr CJ, McCormick F, (2002) The RB and p53 pathways in cancer. Cancer Cell 2: 103-112.
5. Fernandez V, Hartmann E, Ott G, Campo E, Rosenwald A, (2005) Pathogenesis of mantle-cell lymphoma: all oncogenic roads lead to dysregulation of cell cycle and DNA damage response pathways. J Clin Oncol 23: 6364-6369.
6. Liu Q, Alinari L, Chen CS, Yan F, Dalton JT, et al. (2010) FTY720 shows promising in vitro and in vivo preclinical activity by downmodulating Cyclin D1 and phospho-Akt in mantle cell lymphoma. Clin Cancer Res 16: 3182-3192.
7. Chen R, Chubb S, Cheng T, Hawtin RE, Gandhi V, et al. (2010) Responses in mantle cell lymphoma cells to SNS-032 depend on the biological context of each cell line. Cancer Res 70: 6587-6597.
8. Kawamata N, Chen J, Koeffler HP, (2007) Suberoylanilide hydroxamic acid (SAHA; vorinostat) suppresses translation of cyclin D1 in mantle cell lymphoma cells. Blood 110: 2667-2673.
9. Venkataraman G, Maududi T, Ozpuyan F, Bahar HI, Izban KF, et al. (2006) Induction of apoptosis and down regulation of cell cycle proteins in mantle cell lymphoma by flavopiridol treatment. Leuk Res 30: 1377-1384.
10. Klier M, Anastasov N, Hermann A, Meindl T, Angermeier D, et al. (2008) Specific lentiviral shRNA-mediated knockdown of cyclin D1 in mantle cell lymphoma has minimal effects on cell survival and reveals a regulatory circuit with cyclin D2. Leukemia 22: 2097-2105.
11. Tchakarska G, Le Lan-Leguen A, Roth L, Sola B, (2009) The targeting of the sole cyclin D1 is not adequate for mantle cell lymphoma and myeloma therapies. Haematologica 94: 1781-1782.
12. Rao DD, Vorhies JS, Senzer N, Nemunaitis J, (2009) siRNA vs. shRNA: similarities and differences. Adv Drug Deliv Rev 61: 746-759.
13. Amarzguioui M, Lundberg P, Cantin E, Hagstrom J, Behlke MA, et al. (2006) Rational design and in vitro and in vivo delivery of Dicer substrate siRNA. Nat Protoc 1: 508-517.
14. Beltran E, Fresquet V, Martinez-Useros J, Richter-Larrea JA, Sagardoy A, et al. (2011) A cyclin-D1 interaction with BAX underlies its oncogenic role and potential as a therapeutic target in mantle cell lymphoma. Proc Natl Acad Sci U S A 108: 12461-12466.
15. Tiemann K, Alluin JV, Honegger A, Chomchan P, Gaur S, et al. (2011) Small interfering RNAs targeting cyclin D1 and cyclin D2 enhance the cytotoxicity of chemotherapeutic agents in mantle cell lymphoma cell lines. Leuk Lymphoma 52: 2148-2154.
16. Gershoni JM, (1988) Protein blotting: a manual. Methods Biochem Anal 33: 1-58.